drugset / Trial / NCT07329777
Atropine in the Treatment of Myopia Study in Malaysia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical trial is designed to assess the efficacy and safety of Atropine Sulphate 0.025% w/v Eye Drops compared to placebo in a randomized, double-blind, placebo-controlled study for the management of myopia progression in children.
Timeline
- Start
- 2025-09-17
- Primary completion
- 2027-09
- Completion
- 2029-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atropine | Other / unclassified | 0.025 % | Other |